As of January 23, 2025, Trevena (TRVN) has a market cap of $1.607 million USD. According to our data, Trevena is ranked No.9205 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $1.61 M |
24.00%
|
Dec 31, 2024 | $1.30 M |
-91.69%
|
Dec 29, 2023 | $15.59 M |
-49.51%
|
Dec 30, 2022 | $30.88 M |
-90.19%
|
Dec 31, 2021 | $0.31 B |
-72.76%
|
Dec 31, 2020 | $1.16 B |
154.46%
|
Dec 31, 2019 | $0.45 B |
95.58%
|
Dec 31, 2018 | $0.23 B |
-73.13%
|
Dec 29, 2017 | $0.86 B |
-72.79%
|
Dec 30, 2016 | $3.17 B |
-44.00%
|
Dec 31, 2015 | $5.67 B |
75.59%
|
Dec 31, 2014 | $3.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Heron Therapeutics
HRTX
|
$0.25 B |
0.000 M
|
USA
|
Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Market Cap | = | TRVN Stock Price | * | TRVN Shares Outstanding |
= | $1.86 | * | 0.86 M | |
= | $1.61 M |